International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.7951295
Case Report
Neuroendocrine Carcinoma of Gall Bladder: A Case Study
 ,
Published
May 19, 2023
Abstract
Neuroendocrine Carcinoma of Gallbladder is a rare tumor, which is heterogenous neoplasm originating from neuroendocrine cells, which secrete neurotransmitter. Among all theneuroendocrine neoplasms, gallbladder neuroendocrine neoplasm prevalence is 0.5% accounting for approximately 2.1% of all the gallbladder tumors. Case Presentation As gallbladder neuroendocrine neoplasm is a rare lesion it is seldom seenin clinical practice, there is a limited availability of review reports and it is therefore often considered only as a case study. It is difficult to distinguish gallbladder neuroendocrine neoplasms from other gallbladder diseases using imaging diagnostic techniques. We here report a case of 55 years old female presenting with right upper quadrant and epigastric pain and eventually diagnosed with mixed cell neuroendocrine carcinoma of gallbladder. Conclusion Therefore to overcome inherent risks or shortfalls of traditional surgery, early detection, diagnosis and treatment of gallbladder neuroendocrine neoplasms are required to improve patient longevity.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
504 Views
277 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved